Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C179 - Epilepsy: Surgery and Neuromodulation

Wednesday 04/26/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Carol M. Ulloa, MD, FAES, FAAN
Epilepsy/Clinical Neurophysiology (EEG)
Participants should be able to recognize how epilepsy surgery risk is overestimated, evaluate how minimally invasive epilepsy surgery options may mitigate patient surgical risk perception, and identify the surgery evaluation as a collaborative process where patients and physicians make choices based on individual risk tolerance. Participants will also develop a better understanding of neuromodulation for the treatment of epilepsy, including responsive neurostimulation and deep brain stimulation. Through thought-provoking case-based interactive panel discussion, attendees will also analyze surgical decision-making. This program complements Epilepsy: Basics and Considerations Across the Age Span: Pediatrics, Pregnancy, Elderly, and Special Populations, but covers independent topics.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Fellow, Specialist Neurologist
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM EST Introduction Introduction
Carol M. Ulloa, MD, FAES, FAAN
03:35 PM - 04:05 PM EST Speaker Using Minimally Invasive Procedures to Reframe Epilepsy Surgery Consideration
Patrick Landazuri, MD, FAAN
04:05 PM - 04:35 PM EST Speaker Neuromodulation in Epilepsy
Vikram Rao, MD
04:35 PM - 05:30 PM EST Speaker Cases with Panel Discussion
Carol M. Ulloa, MD, FAES, FAAN, Vikram Rao, MD, Patrick Landazuri, MD, FAAN, Barbara C. Jobst, MD, FAAN
Faculty Disclosures
Carol M. Ulloa, MD, FAES, FAAN The institution of Dr. Ulloa has received research support from medtronics. An immediate family member of Dr. Ulloa has received research support from NIH.
Vikram Rao, MD Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. The institution of Dr. Rao has received research support from NeuroPace, Inc.. The institution of Dr. Rao has received research support from Medtronic.
Patrick Landazuri, MD, FAAN Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Barbara C. Jobst, MD, FAAN Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from Harvard Pilgrim. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.